Clinical Trial Update: Subcutaneous Immunotherapy for Mouse in Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating subcutaneous immunotherapy using mouse allergen extract in adults with asthma or perennial allergic rhinitis; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Perennial Allergic Rhinitis

Drugs mentioned

• Mouse allergen subcutaneous immunotherapy (mouse allergen extract subcutaneous immunotherapy)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Asthma, Perennial Allergic Rhinitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-11-28